| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $607,689,596 ) (Continued on the next page) |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | S10OD036457 | A High Throughput and High Sensitivity Mass Spectrometer for Proteomics Studies on Human Diseases | 000 | 1 | NIH | 7/26/2024 | $1,352,820 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH092638 | Offline memory processing in schizophrenia | 000 | 10 | NIH | 12/19/2023 | $755,759 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS112183 | Cellular Mechanisms of Transcranial Magnetic Stimulation in Cerebellar Cortex | 000 | 2 | NIH | 8/9/2024 | $564,257 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23MH133876 | A Randomized Controlled Trial of A Smartphone Delivered Treatment for Suicidal Thoughts and Behavior | 000 | 1 | NIH | 8/31/2024 | $195,947 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32MH139173 | Advanced functional MRI of cerebral cortical layers in the human brain using ultrahigh-resolution linescan MRI technology | 000 | 1 | NIH | 8/30/2024 | $78,328 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL149647 | Cardiac resident macrophages in AV node conduction | 001 | 3 | NIH | 6/13/2024 | $57,877 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21DA061215 | Xylazine and fentanyl effects on rat breathing, metabolism, and thermoregulation | 000 | 1 | NIH | 6/28/2024 | $230,521 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K99AG083056 | Imaging brain-wide subarachnoid and perivascular cerebrospinal fluid flow in aging and Alzheimer's disease | 000 | 2 | NIH | 7/31/2024 | $133,920 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32HL176334 | Development of Capillary-on-Chip for the Study of Preservation Injury on Microvascular Endothelial Cells | 000 | 1 | NIH | 9/10/2024 | $76,984 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI146785 | Defining the Fc-correlates of protection against influenza | 001 | 5 | NIH | 2/22/2024 | $541,125 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21EB032932 | High-Resolution Lymphatic Mapping of the Upper Extremities with MRI | 004 | 3 | NIH | 8/23/2024 | $201,000 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01DK140244 | Control of allelic Gsα expression for regulating hormone signaling | 000 | 1 | NIH | 9/2/2024 | $553,545 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD105266 | The Genomic Architecture of Pregnancy Loss | 000 | 4 | NIH | 8/20/2024 | $831,619 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R25MH119857 | Fostering diversity in the next generation of HIV researchers to improve the HIV continuum of care | 000 | 5 | NIH | 7/22/2024 | $269,152 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | OT2NS122680 | EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2) | 002 | 1 | NIH | 7/26/2024 | $2,226,370 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL092577 | IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL | 001 | 16 | NIH | 6/20/2024 | $57,659 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI170850 | Long COVID as a putative subtype of chronic fatigue syndrome | 000 | 3 | NIH | 7/23/2024 | $351,594 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI176533 | Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons | 001 | 2 | NIH | 5/22/2024 | $85,946 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | P30AG062421 | Massachusetts Alzheimer's Disease Research Center (MADRC) | 001 | 6 | NIH | 5/20/2024 | $4,832,741 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS119483 | Targeting Pathologic Spike-Ripples to Isolate and Disrupt Epileptic Dynamics | 001 | 4 | NIH | 4/11/2024 | $47,772 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH120402 | Longitudinal neuroprotectiveeffects of periconceptional folic acid supplements in help-seeking youth with psychiatric symptomsand healthy controls | 000 | 5 | NIH | 5/21/2024 | $245,353 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH120402 | Longitudinal neuroprotectiveeffects of periconceptional folic acid supplements in help-seeking youth with psychiatric symptomsand healthy controls | 000 | 5 | NIH | 5/21/2024 | $745,823 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | P30AG062421 | Massachusetts Alzheimer's Disease Research Center (MADRC) | 004 | 6 | NIH | 8/7/2024 | $352,507 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | P30AG062421 | Massachusetts Alzheimer's Disease Research Center (MADRC) | 004 | 6 | NIH | 8/7/2024 | $6,931 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG065254 | Using the Emergency Department Visit to Promote Advance Care Planning | 000 | 4 | NIH | 6/6/2024 | $540,064 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K01MH135745 | The Impact of an Intervention to Reduce Pharmacists' Racial Bias Towards People of Color at Risk of HIV | 000 | 1 | NIH | 8/21/2024 | $181,903 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23NS118048 | Clinical and Non-Invasive Biomarkers of Myotonic Dystrophy | 000 | 2 | NIH | 11/27/2023 | $200,880 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | P01HL158504 | New Approaches to Inducing Cardiac Allograft Tolerance | 000 | 4 | NIH | 7/17/2024 | $2,377,801 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH130899 | Leveraging computational strategies to disentangle the genetic and neural underpinnings of ADHD and its associated cognitive systems | 000 | 2 | NIH | 8/21/2024 | $732,244 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD111355 | Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value | 001 | 3 | NIH | 8/7/2024 | $419,752 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01DK124223 | Oxytocin as a Neuroendocrine Therapy for Obesity in Youth | 000 | 4 | NIH | 7/25/2024 | $692,474 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH129367 | Probing the Functional and Behavioral Impact of Precision Circuit Modulation in Neuropsychiatric Disorders | 000 | 3 | NIH | 7/26/2024 | $831,844 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD111355 | Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value | 000 | 3 | NIH | 8/2/2024 | $786,575 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | S10MH133576 | Next-Generation 3 Tesla Human MRI Scanner for Mental Health Research | 000 | 1 | NIH | 8/16/2024 | $600,000 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R18HS029430 | Evaluating the Feasibility of Lung Cancer Screening in High-Risk Black Women | 000 | 2 | AHRQ | 8/1/2024 | $499,296 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH124694 | Alignment of cortical development trajectories with emergent dimensional psychopathology and related risk factors among early adolescents in the ABCD Study | 000 | 5 | NIH | 8/24/2024 | $420,000 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD111355 | Adolescent-tailored HIV treatment and prevention strategies in South Africa: projecting clinical benefits and value | 002 | 3 | NIH | 8/12/2024 | $7,945 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K76AG083309 | Incorporating Geriatric Constructs into Management of Inflammatory Bowel Diseases in Older Adults | 000 | 2 | NIH | 7/10/2024 | $243,000 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI177555 | A comprehensive investigation of Pseudomonas quorum sensing regulatory relationships and the consequences on quorum sensing inhibitors in complex communities | 000 | 2 | NIH | 6/28/2024 | $750,050 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL163273 | Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy | 001 | 2 | NIH | 6/12/2024 | $57,376 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS119483 | Targeting Pathologic Spike-Ripples to Isolate and Disrupt Epileptic Dynamics | 000 | 4 | NIH | 12/14/2023 | $614,230 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K08AI171166 | Mechanistic characterization of vaginal microbiome-metabolome associations and metabolite-mediated host inflammation | 000 | 2 | NIH | 2/15/2024 | $182,304 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL162373 | Statistical Methods in COVID-19/PASC Clinical Research | 000 | 2 | NIH | 2/16/2024 | $419,861 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R37AI058736 | Optimizing HIV Care in Less Developed Countries | 003 | 20 | NIH | 7/29/2024 | $991,928 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U24NS131158 | Neurofibromatosis and Schwannomatosis Genes Variant Curation Expert Panel (VCEP) | 001 | 1 | NIH | 8/28/2024 | -$69,336 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R37AI058736 | Optimizing HIV Care in Less Developed Countries | 004 | 20 | NIH | 7/30/2024 | $8,781 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21AG086927 | Imaging of Mitochondial Complex I function in Down Syndrome | 000 | 1 | NIH | 7/29/2024 | $250,500 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL163273 | Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy | 000 | 2 | NIH | 12/20/2023 | $645,497 |
| | 2024 | 2024 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | U24NS131158 | Neurofibromatosis and Schwannomatosis Genes Variant Curation Expert Panel (VCEP) | 002 | 1 | NIH | 9/12/2024 | $83,500 |
|
